136 related articles for article (PubMed ID: 20113904)
1. Update on thalassemia: clinical care and complications.
Cunningham MJ
Hematol Oncol Clin North Am; 2010 Feb; 24(1):215-27. PubMed ID: 20113904
[TBL] [Abstract][Full Text] [Related]
2. Update on thalassemia: clinical care and complications.
Cunningham MJ
Pediatr Clin North Am; 2008 Apr; 55(2):447-60, ix. PubMed ID: 18381095
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
Sadelain M
Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
[TBL] [Abstract][Full Text] [Related]
4. Alpha and beta thalassemia.
Muncie HL; Campbell J
Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
[TBL] [Abstract][Full Text] [Related]
5. [Beta-thalassemia: clinical manifestations].
Perrimond H
Bull Soc Pathol Exot; 2001 May; 94(2):92-4. PubMed ID: 11475035
[TBL] [Abstract][Full Text] [Related]
6. Thalassemia intermedia: revisited.
Taher A; Isma'eel H; Cappellini MD
Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
[TBL] [Abstract][Full Text] [Related]
7. The hypercoagulable state in thalassemia intermedia.
Taher AT; Musallam KM; Inati A
Hemoglobin; 2009; 33 Suppl 1():S160-9. PubMed ID: 20001621
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for homozygous beta-thalassemia. Is it a reality?
Boulad F; Rivière I; Sadelain M
Hemoglobin; 2009; 33 Suppl 1():S188-96. PubMed ID: 20001625
[TBL] [Abstract][Full Text] [Related]
9. Thalassemia syndromes. Recent advances.
Ohene-Frempong K; Rappaport E; Schwartz E
Hematol Oncol Clin North Am; 1987 Sep; 1(3):503-19. PubMed ID: 3329184
[TBL] [Abstract][Full Text] [Related]
10. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
Malik P; Arumugam PI; Yee JK; Puthenveetil G
Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
[TBL] [Abstract][Full Text] [Related]
11. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
Bank A
Pediatr Hematol Oncol; 2008; 25(1):1-4. PubMed ID: 18231949
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation for inherited diseases.
O'Marcaigh AS; Cowan MJ
Curr Opin Oncol; 1997 Mar; 9(2):126-30. PubMed ID: 9161789
[TBL] [Abstract][Full Text] [Related]
13. Insight onto the pathophysiology and clinical complications of thalassemia intermedia.
Cappellini MD; Musallam KM; Taher AT
Hemoglobin; 2009; 33 Suppl 1():S145-59. PubMed ID: 20001620
[TBL] [Abstract][Full Text] [Related]
14. Response to hydroxyurea therapy in beta-thalassemia.
Koren A; Levin C; Dgany O; Kransnov T; Elhasid R; Zalman L; Palmor H; Tamary H
Am J Hematol; 2008 May; 83(5):366-70. PubMed ID: 18181203
[TBL] [Abstract][Full Text] [Related]
15. Unexpected complications after bone marrow transplantation in transfusion-dependent children.
Saunders EF; Olivieri N; Freedman MH
Bone Marrow Transplant; 1993; 12 Suppl 1():88-90. PubMed ID: 8374573
[TBL] [Abstract][Full Text] [Related]
16. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
Colah R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Surve R; Subramaniam PG; Bondge N; Pujari K; Ghosh K; Mohanty D
Blood Cells Mol Dis; 2004; 33(2):153-7. PubMed ID: 15315795
[TBL] [Abstract][Full Text] [Related]
17. [Obstructive-restrictive pulmonary syndrome as long-term side effect of bone marrow transplantation in thalassemia major. Prognostic and therapeutic problems].
La Placa G; Uderzo C; Andreotti M; Urbano M; Petroni F; Corbella E
Pediatr Med Chir; 1995; 17(2):131-3. PubMed ID: 7610075
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of asymptomatic beta-thalassemia major in an African American individual.
Ballas SK; Cai SP; Gabuzda T; Chehab FF
Am J Med Genet; 1997 Mar; 69(2):196-9. PubMed ID: 9056561
[TBL] [Abstract][Full Text] [Related]
19. Thalassemia intermedia today: should patients regularly receive transfusions?
Aessopos A; Kati M; Meletis J
Transfusion; 2007 May; 47(5):792-800. PubMed ID: 17465943
[TBL] [Abstract][Full Text] [Related]
20. Targeted correction of the point mutations of beta-thalassemia and targeted mutagenesis of the nucleotide associated with HPFH by RNA/DNA oligonucleotides: potential for beta-thalassemia gene therapy.
Li ZH; Liu DP; Yin WX; Guo ZC; Liang CC
Blood Cells Mol Dis; 2001; 27(2):530-8. PubMed ID: 11500064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
